Medpace Expands in Eastern Europe with Acquisition
Cincinnati-based contract research organization (CRO) Medpace made its first acquisition with the purchase of Monax, a CRO based in Prague, that it has worked with previously. The deal was a classic partnership turned purchase for the CRO. But the acquisition was a departure from Medpace’s stated organic growth-only philosophy. However, according to Dr. August Troendle, chief executive officer at Medpace, it was a cementing of a working partnership rather than a merger.
Promedica Forms Alliance with Russian CRO Synergy Research Group
Less than a year ago, Costa Mesa, Calf.-based contract research organization (CRO) Promedica International set out to find a suitable Russian CRO to form an alliance that would expand its geographical reach. Its plan was to tap into the emerging Russian clinical trials market by working with a local company already familiar with the country's clinical research environment. Just about the same time, Moscow-based Synergy Research Group began looking for the same type of partnership: a U.S.-based CRO with a large pool of international clients and the capability of conducting large trials in the West.
Other breaking news...
Company Profile: An interview with Charles H. Ballow, PharmD, director, Buffalo Clinical Research Center